Document:

exv10w32

 

Exhibit 10.32

THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS

AMENDED (THE “ACT”) AND IS NOT TRANSFERABLE EXCEPT AS PROVIDED HEREIN.

Warrant

to Purchase One (1) Unit

of

Smart Move, Inc.

(A Delaware Corporation)

     THIS CERTIFIES THAT, for value received, [                    ] or its assigns, (the “Holder”), as
registered owner of this warrant (the “Warrant”), is entitled to purchase and receive, in whole or
in part, subject to the provisions of this Warrant, from Smart Move, Inc., a Delaware corporation
(the “Company”), up to [                    ] fully paid, validly issued and nonassessable Units (the “Units”),
of the Company, at a price per Unit equal to $                     (the “Initial Exercise Price”) (125% of
the initial public offering price per Unit); provided, however, that the number and kind of
securities for which the Warrants are exercisable are subject to further adjustment in certain
events, such as mergers, splits, stock dividends, recapitalizations and the like, to prevent
dilution, as set forth herein. The Units will be identical to the units offered to the public
except that the exercise price of the warrant included in each Unit will have an exercise price
equal to 168% of the unit initial public offering price. This Warrant shall be exercisable at any
time and from time to time during the period commencing on the date hereof (the “Commencement
Date”) up to and including                                         , 2011 (the “Expiration Date”) (five years from the
date hereof), and subject to the terms and conditions set forth herein. If the Expiration Date is
a day on which banking institutions are authorized by law to close, then this Warrant may be
exercised on the next succeeding day which is not such a day in accordance with the terms herein.
During the period beginning on the Commencement Date and ending on the Expiration Date, the Company
agrees not to take any action that would terminate the Warrant.

     Section 1. Exercise.

          Section 1.1 Exercise Form. In order to exercise this Warrant, the exercise
form attached hereto must be duly executed and completed and delivered to the Company,
together with this Warrant and payment of the Exercise Price in cash or by certified check
or official bank check for the Warrant Shares being purchased. If the subscription rights
represented hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the
Expiration Date, this Warrant shall become and be void without further force or effect, and
all rights represented hereby shall cease and expire.

          Section 1.2 Conversion Right.

               Section 1.2.1 Determination of Amount. In lieu of the payment of the Exercise
Price in the manner required by Section 1.1, the Holder shall have the right (but not the
obligation) to convert any exercisable but unexercised portion of this Warrant into Warrant
Shares (the “Conversion Right”) as follows. Upon exercise of the Conversion Right, the
Company shall deliver to the Holder (without payment by the Holder of any of the Exercise
Price in cash) that number of Warrant Shares equal to the quotient obtained by dividing (x)
the “Value” (as defined below), at the close of trading on the next to last trading day
immediately preceding the exercise of the Conversion Right, of the portion of the Warrant
being converted by (y) the “Market Price” (as defined below). The “Value” of the portion of
the Warrant being converted shall equal the remainder derived from subtracting (a) the
Exercise Price multiplied by the number of Warrant Shares underlying that portion of the
Warrant being converted from (b) the Market Price of the Warrant Shares multiplied by the
number of Warrant Shares underlying that portion of the Warrant being converted. As used in
this herein, the term “Market Price” at any date shall be deemed to be the sum of (A) the
average last reported sale price of the shares for the five trading days ending

 

 

on the next to last trading day immediately preceding the exercise of the Conversion
Right as officially reported by the principal securities exchange on which the shares are
listed or admitted to trading, or, if the shares are not listed or admitted to trading on any
national securities exchange or if any such exchange on which the shares are listed is not
its principal trading market, the average last reported sale price for such five trading days
as furnished by the NASD through the Nasdaq National Market or Capital Market, or The
American Stock Exchange, or if applicable, the OTC Bulletin Board, or if the shares are not
listed or admitted to trading on any of the foregoing markets, or similar organization, as
determined in good faith by resolution of the Board of Directors of the Company, based on the
best information available to it and (B) the intrinsic value of the Warrant using the
share price determined in (A).

               Section 1.2.2 Mechanics of Conversion. The Conversion Right may be exercised by
the Holder on any business day on or after the Commencement Date and not later than the
Expiration Date by delivering the Warrant with a duly executed exercise form attached hereto
with the Conversion Right section completed to the Company, exercising the Conversion Right
and specifying the total number of Warrant Shares that the Holder will purchase pursuant to
such Conversion Right.

     Section 2. Transfer.

          Section 2.1 General Restrictions. The registered Holder of this Warrant, by
its acceptance hereof, agrees that it will not sell, transfer or assign or hypothecate this
Warrant (or any of the securities that may be acquired upon the exercise of this Warrant)
prior to one (1) year from the Effective Date to anyone other than (i) an officer or partner
of such Holder, (ii) an officer of Newbridge Securities Corporation, the managing
underwriter and one of the representatives of the underwriters of the public offering with
respect to which this Warrant has been issued (“Underwriters”), or an officer or partner of
any Underwriter or of any selected dealer in connection with the Company’s public offering
with respect to which this Warrant has been issued, or (iii) any Underwriter or selected
dealer. Commencing one (1) year after the Effective Date, transfers to others may be made
subject to compliance with or exemptions from applicable securities laws. In order to make
any permitted assignment, the Holder must deliver to the Company the assignment form
attached hereto duly executed and completed, together with the Warrant and payment of all
transfer taxes, if any, payable in connection therewith. The Company shall immediately
transfer this Warrant on the books of the Company and shall execute and deliver a new
Warrant of like tenor to the appropriate assignee(s) expressly evidencing the right to
purchase the aggregate number of Warrant Shares purchasable hereunder or such portion of
such number as shall be contemplated by any such assignment.

          Section 2.2 Restrictions Imposed by the Act. This Warrant and the securities
underlying this Warrant shall not be transferred unless and until (i) the Company has
received the opinion of counsel for the Holder that this Warrant or the Warrant Shares, as
the case may be, may be transferred pursuant to an exemption from registration under the Act
and applicable state law, the availability of which is established to the reasonable
satisfaction of the Company (the Company hereby agreeing that an opinion of Cozen O’Connor
shall be deemed satisfactory evidence of the availability of an exemption), or (ii) a
registration statement relating to such Warrant or Warrant Shares, as the case may be, has
been filed by the Company and declared effective by the Securities and Exchange Commission
(the “Commission”) and compliance with applicable state law.

2

 

     Section 3. New Warrants to be Issued.

          Section 3.1 Partial Exercise or Transfer. Subject to the restrictions in
Section 3 hereof, this Warrant may be exercised or assigned in whole or in part. In the
event of the exercise or assignment hereof in part only, upon surrender of this Warrant for
cancellation, together with the duly executed exercise or assignment form and funds
sufficient to pay any Exercise Price and/or transfer tax, the Company shall cause to be
delivered to the Holder without charge a new Warrant of like tenor to this Warrant in the
name of the Holder evidencing the right of the Holder to purchase the aggregate number of
Warrant Shares purchasable hereunder as to which this Warrant has not been exercised or
assigned.

          Section 3.2 Lost Certificate. Upon receipt by the Company of evidence
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant and of
reasonably satisfactory indemnification, and upon surrender and cancellation of the
Warrants, if mutilated, the Company shall execute and deliver a new Warrant of like tenor
and date. Any such new Warrant executed and delivered as a result of such loss, theft,
mutilation or destruction shall constitute a substitute contractual obligation on the part
of the Company.

     Section 4. Registration Rights.

          Section 4.1 Registration. This Warrant and all of the securities that are
directly or indirectly issuable upon exercise of the Warrant (the Warrant and such
securities collectively referred to hereinafter as the “Registrable Securities”) shall be
registered by filing a registration statement on an appropriate form with the SEC, and the
Company covenants and agrees to maintain the effectiveness of the Registration Statement
until the Expiration Date. Notwithstanding the foregoing, in the event that, prior to the
Expiration Date, the Company ceases to be eligible under the Securities Act of 1933, as
amended (the “Act”) or the rules and regulations promulgated thereunder, to maintain a
registration statement on Form S-3, or in the event that the Warrant or the Registrable
Securities cease to be eligible for inclusion in such Registration Statement to the extent
necessary to permit the Holder to exercise the Warrants and sell the Registrable Securities
without restriction under the Act, the Company will promptly (and in any event within 10
days of the date that the Warrants or any Registrable Securities cease to be so eligible),
amend or file a new registration statement under the Act on a form eligible for use by the
Company for the registration of such securities and use its best efforts to have such
registration statement declared effective by the Commission as soon as practicable after
such filing, which registration statement shall include such information as may be required
to permit the exercise of the Warrant and the sale of the Registrable Securities without
restriction under the Act. The Holder acknowledges and agrees that the Warrant shall be
exercisable pursuant to any such registration statement only at such times as the
registration statement is effective or in accordance with any applicable exemption from the
registration requirements of the Act. Upon such Registration Statement’s being declared
effective by the Commission, the Company shall use its best efforts to cause the
Registration Statement to remain effective until the Expiration Date. During such time as
the Registrable Securities registered pursuant to any registration statement under the Act,
the Company further covenants and agrees to make timely filings of all documents required by
be filed under the Act or the Exchange Act in order to ensure that the registration
statement, including the documents incorporated by reference therein, if any, do not contain
an untrue statement of a material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements therein not misleading.

3

 

          Section 4.2 Expenses. The Company shall bear all fees and expenses attendant to
registering the Registrable Securities.

          Section 4.3 Exercise of Warrants. Nothing contained in this Warrant shall be
construed as requiring the Holder(s) to exercise their Warrants prior to or after the
initial filing of any registration statement or the effectiveness thereof.

          Section 4.4 Documents to be Delivered by Holder(s). Each of the Holder(s)
participating in any of the foregoing offerings shall furnish to the Company a completed and
executed questionnaire provided by the Company requesting information customarily sought of
selling securityholders.

          Section 4.5 Remedies. The Company stipulates that the remedies at law of the
Holder of Registrable Securities in the event of any default or threatened default by the
Company in the performance of or compliance with any of the terms of this Warrant are not
and will not be adequate, and that such terms may be specifically enforced by a decree for
the specific performance of any agreement contained herein or by an injunction restraining
any breach, actual or threatened, of the terms of this Warrant, without the necessity of
showing economic loss. The remedies provided herein shall be cumulative and in addition to
all other remedies available under this Warrant, at law or in equity, and nothing herein
shall limit the right of the Holder to pursue actual damages for any failure by the Company
to comply with the terms of the Warrant.

          Section 4.6 Demand Registration. (a) The Company, upon written demand (the
“Initial Demand Notice”) of the Holder(s) of at least 51% of the Warrants and/or the
Registrable Securities (the “Majority Holders”), agrees to register on one (1) occasion,
all or any portion of the Registrable Securities. On such occasion, the Company will file a
registration statement or a post-effective amendment to the Registration Statement covering
the Registrable Securities within sixty days after receipt of the Initial Demand Notice and
use its best efforts to have such registration statement or post-effective amendment
declared effective as soon as possible thereafter. The demand for registration may be made
at any time during a period commencing twelve (12) months from the Effective Date and for a
period of three (3) years thereafter. The Company covenants and agrees to give written
notice of its receipt of any Initial Demand Notice by any Holder(s) to all other registered
Holders of the Warrants and/or the Registrable Securities within ten (10) days from the date
of the receipt of any such Initial Demand Notice.

           (b) The Company shall bear all fees and expenses attendant to registering the
Registrable Securities, including the expenses of any legal counsel selected by the Holders
to represent them in connection with the sale of the Registrable Securities, but the Holders
shall pay any and all underwriting commissions. The Company agrees to use its reasonable
best efforts to qualify or register the Registrable Securities in such states as are
reasonably requested by the Majority Holder(s); provided, however, that in no event shall
the Company be required to register the Registrable Securities in a state in which such
registration would cause (i) the Company to be obligated to qualify to do business in such
state, or would subject the Company to taxation as a foreign corporation doing business in
such jurisdiction or (ii) the principal stockholders of the Company to be obligated to
escrow their shares of capital stock of the Company. The Company shall cause any
registration statement or post-effective amendment filed pursuant to the demand rights
granted under Section 4.6(a) to remain effective for a period of nine (9) consecutive months
from the effective date of such registration statement or post-effective amendment.

4

 

          4.7. “Piggy-Back” Registration. (a) In addition to the demand right of
registration, the Holders of the Registsrable Securities shall have the right for a period
of three (3) years commencing on the Effective Date, to include the Registrable Securities
as part of any other registration of securities filed by the Company (other than in
connection with a transaction contemplated by Rule 145(a) promulgated under the Act or
pursuant to Form S-8); provided, however, that if, in the written opinion of the Company’s
managing underwriter or underwriters, if any, for such offering, the inclusion of the
Registrable Securities, when added to the securities being registered by the Company or the
selling stockholder(s), will exceed the maximum amount of the Company’s securities which
can be marketed (i) at a price reasonably related to their then current market value, and
(ii) without materially and adversely affecting the entire offering, then the Company will
still be required to include the Registrable Securities, but may require the Holders to
agree, in writing, to delay the sale of all or any portion of the Registrable Securities
for a period of ninety (90) days from the Effective Date of the offering; provided, further,
that if the sale of any Registrable Securities is so delayed, then the number of securities
to be sold by all stockholders in such public offering during such ninety (90) day period
shall be apportioned pro rata among all such selling stockholders, including all holders of
the Registrable Securities, according to the total amount of securities of the Company
owned by said selling stockholders, including all holders of the Registrable
Securities. 

            4.8. Costs of Registration. The Company shall bear all fees and
expenses attendant to registering the Registrable Securities pursuant to Section 4.7,
including the reasonable expenses of legal counsel selected by the Holders to represent them
in connection with the sale of the Registrable Securities, but the Holders shall pay any and
all underwriting commissions related to the Registrable Securities. In the event of such a
proposed registration, the Company shall furnish the then Holders of outstanding
Registrable Securities with not less than ten (10) days written notice prior to the proposed
date of filing of such registration statement. Such notice to the Holders shall continue to
be given for each applicable registration statement filed (during the period in which the
Warrant is exercisable) by the Company until such time as all of the Registrable Securities
have been registered and sold. The holders of the Registrable Securities shall exercise the
“piggy-back” rights provided for herein by giving written notice, within ten (10) days of
the receipt of the Company’s notice of its intention to file a registration statement. The
Company shall cause any registration statement filed pursuant to the above “piggyback”
rights to remain effective for at least nine (9) months from the date that the Holders of
the Registrable Securities are first given the opportunity to sell all of such securities.

          4.9. Indemnification. The Company shall indemnify the Holder(s) of
the Registrable Securities to be sold pursuant to any registration statement hereunder and
each person, if any, who controls such Holders within the meaning of Section 15 of the Act
or Section 20(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
against all loss, claim, damage, expense or liability (including all reasonable attorneys’
fees and other expenses reasonably incurred in investigating, preparing or defending
against litigation, commenced or threatened, or any claim whatsoever whether arising out of
any action between Newbridge Securities Corporation (the “Manager”) and the Company or
between the Manager and any third party or otherwise) to which any of them may become
subject under the Act, the Exchange Act or otherwise, arising from such registration
statement but only to the same extent and with the same effect as the provisions pursuant
to which the Company has agreed to indemnify the Underwriters contained in Section 5 of the
Underwriting Agreement (as defined below) between the Company, the Underwriter and the other
underwriters named therein dated the Effective Date. The Holder(s) of the Registrable
Securities to be sold pursuant to such registration statement, and their successors and
assigns, shall severally, and not jointly, indemnify

5

 

the Company, its officers and directors and each person, if any, who controls the Company
within the meaning of Section 15 of the Act or Section 20(a) of the Exchange Act, against
all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and
other expenses reasonably incurred in investigating, preparing or defending against any
claim whatsoever) to which they may become subject under the Act, the Exchange Act or
otherwise, arising from information furnished by or on behalf of such Holders, or their
successors or assigns, in writing, for specific inclusion in such registration statement to
the same extent and with the same effect as the provisions contained in Section 5 of the
Underwriting Agreement pursuant to which the Underwriters have agreed to indemnify the
Company.

          4.10. No Requirement to Exercise. Nothing contained in this Warrant
shall be construed as requiring the Holder(s) to exercise their Warrants prior to or after
the initial filing of any registration statement or the effectiveness thereof.

          4.11. Effect of Rule 144. Notwithstanding anything contained in
this Section 4 to the contrary, the Company shall have no obligation for the registration
of Registrable Securities held by any Holder (i) where such Holder would then be entitled to
sell under Rule 144 within any three-month period (or such other period prescribed under
Rule 144 as may be provided by amendment thereof) all of the Registrable Securities then
held by such Holder, and (ii) where the number of Registrable Securities held by such
Holder is within the volume limitations under paragraph (e) of Rule 144 (calculated as if
such Holder were an affiliate within the meaning of Rule 144).

          4.12. Notice to Company. Each Holder agrees, that upon receipt of
any notice from the Company or the happening of any event as a result of which the
prospectus included in Registration Statement, as then in effect, includes an untrue
statement of a material fact or omits to state a material fact required to be stated
therein or necessary to make the statements therein not misleading in light of the
circumstances then existing, such Holder will immediately discontinue disposition of
Registrable Securities pursuant to the Registration Statement covering such Registrable
Securities until such Holder’s receipt of the copies of a supplemental or amended
prospectus, and, if so desired by the Company, such Holder shall deliver to the Company (at
the expense of the Company) or destroy (and deliver to the Company a certificate of such
destruction) all copies, other than permanent file copies then in such Holder’s possession,
of the prospectus covering such Registrable Securities current at the time of receipt of
such notice.

     Section 5. Adjustments.

          Section 5.1 Adjustments to Exercise Price and Number of Securities. The
Exercise Price and the number of the Warrant Shares underlying the Warrant shall be subject
to adjustment from time to time as hereinafter set forth:

               Section 5.1.1 If after the date hereof, and subject to the provisions of Section 5.2
below, the number of outstanding shares of Common Stock is increased by a stock dividend
payable in shares of Common Stock or by a split-up of shares of Common Stock or other similar
event, then, on the effective date thereof, the number of shares of Common Stock underlying
the Warrant shall be increased in proportion to such increase in outstanding shares.

               Section 5.1.2 If after the date hereof, and subject to the provisions of Section 5.2,
the number of outstanding shares of Common Stock is decreased by a consolidation,

6

 

combination or reclassification of shares of Common Stock or other similar event, then,
on the effective date thereof, the number of shares of Common Stock underlying the Warrant
shall be decreased in proportion to such decrease in outstanding shares.

               Section 5.1.3 In case of any reclassification or reorganization of the outstanding
shares of Common Stock other than a change covered by Section 5.1.1 or 5.1.2 hereof or that
solely affects the par value of such shares of Common Stock, or in the case of any merger or
consolidation of the Company with or into another corporation (other than a consolidation or
merger in which the Company is the continuing corporation and that does not result in any
reclassification or reorganization of the outstanding shares of Common Stock), or in the case
of any sale or conveyance to another corporation or entity of the property of the Company as
an entirety or substantially as an entirety in connection with which the Company is
dissolved, the Holder of this Warrant shall have the right thereafter (until the expiration
of the right of exercise of this Warrant) to receive upon the exercise hereof, for the same
aggregate Exercise Price payable hereunder immediately prior to such event, the kind and
amount of shares of stock or other securities or property (including cash) receivable upon
such reclassification, reorganization, merger or consolidation, or upon a dissolution
following any such sale or transfer, by a Holder of the number of shares of Common Stock of
the Company obtainable upon exercise of this Warrant immediately prior to such event; and if
any reclassification also results in a change in shares of Common Stock covered by Section
5.1.1 or 5.1.2, then such adjustment shall be made pursuant to Sections 5.1.1, 5.1.2 and
this Section 5.1.3. The provisions of this Section 5.1.3 shall similarly apply to successive
reclassifications, reorganizations, mergers or consolidations, sales or other transfers.

               Section 5.1.4 This form of Warrant need not be changed because of any change pursuant to
this Section, and Warrants issued after such change may state the same Exercise Price and the
same number of Warrant Shares as are stated in the Warrant initially issued pursuant to this
Agreement. The acceptance by any Holder of the issuance of new Warrant reflecting a required
or permissive change shall not be deemed to waive any rights to an adjustment occurring after
the Commencement Date or the computation thereof.

               Section 5.1.5 In case of any consolidation of the Company with, or merger of the Company
with, or merger of the Company into, another corporation (other than a consolidation or
merger which does not result in any reclassification or change of the outstanding Common
Stock), the corporation formed by such consolidation or merger shall execute and deliver to
the Holder a replacement Warrant providing that the holder of each Warrant then outstanding
or to be outstanding shall have the right thereafter (until the stated expiration of such
Warrant) to receive, upon exercise of such Warrant the kind and amount of shares of stock and
other securities and property receivable upon such consolidation or merger, by a holder of
the number of shares of Common Stock of the Company for which such Warrant might have been
exercised immediately prior to such consolidation, merger, sale or transfer. Such replacement
Warrant shall provide for adjustments which shall be identical to the adjustments provided in
Section 5. The above provision of this Section shall similarly apply to successive
consolidations or mergers.

          Section 5.2 Elimination of Fractional Interests. The Company shall not be
required to issue certificates representing fractions of shares of Common Stock or Warrants
upon the exercise of the Warrant, nor shall it be required to issue scrip or pay cash in
lieu of any fractional interests, it being the intent of the parties that all fractional
interests shall be eliminated by rounding any fraction down to the nearest whole number of
Warrants, shares of Common Stock or other securities, properties or rights.

7

 

     Section 6. Reservation and Listing.

          The Company shall at all times reserve and keep available out of its authorized shares
of Common Stock, solely for the purpose of issuance upon exercise of the Warrant such number
of shares of Common Stock or other securities, properties or rights as shall be issuable
upon the exercise thereof. The Company covenants and agrees that, upon exercise of the
Warrant and payment of the Exercise Price therefor, all shares of Common Stock and other
securities issuable upon such exercise shall be duly and validly issued, fully paid and
non-assessable and not subject to preemptive rights of any stockholder. As long as the
Warrant shall be outstanding, the Company shall use its best efforts to cause all Warrant
Shares issuable upon exercise of the Warrant to be listed (subject to official notice of
issuance) on all securities exchanges (or, if applicable on the Nasdaq National Market,
Capital Market, The American Stock Exchange, OTC Bulletin Board or any successor trading
market) on which the Common Stock or the Public Warrants issued to the public in connection
herewith may then be listed and/or quoted.

     Section 7. Certain Notice Requirements.

          Section 7.1 Holder’s Right to Receive Notice. Nothing herein shall be
construed as conferring upon the Holder the right to vote or consent as a stockholder for
the election of directors or any other matter, or as having any rights whatsoever as a
stockholder of the Company. If, however, at any time prior to the expiration of the Warrant
and its exercise, any of the events described in Section 7.2 shall occur, then, in one or
more of said events, the Company shall give written notice of such event at least fifteen
(15) days prior to the date fixed as a record date or the date of closing the transfer books
for the determination of the stockholders entitled to such dividend, distribution,
conversion or exchange of securities or subscription rights, or entitled to vote on such
proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record
date or the date of the closing of the transfer books, as the case may be. Notwithstanding
the foregoing, the Company shall deliver to the Holder a copy of each notice given to the
other stockholders of the Company at the same time and in the same manner that such notice
is given to the stockholders.

          Section 7.2 Enumerated Events. The Company shall be required to give the notice
described in this Section 7 upon one or more of the following events: (i) if the Company
shall take a record of the holders of its shares of Common Stock for the purpose of
entitling them to receive a dividend or distribution payable otherwise than in cash, or a
cash dividend or distribution payable otherwise than out of retained earnings, as indicated
by the accounting treatment of such dividend or distribution on the books of the Company, or
(ii) the Company shall offer to all the holders of its Common Stock any additional shares of
capital stock of the Company or securities convertible into or exchangeable for shares of
capital stock of the Company, or any option, right or warrant to subscribe therefor, or
(iii) a dissolution, liquidation or winding up of the Company (other than in connection with
a consolidation or merger) or a sale of all or substantially all of its property, assets and
business shall be proposed by the Company.

          Section 7.3 Change in Exercise Price. The Company shall, promptly after an
event requiring a change in the Exercise Price pursuant to Section 7 hereof, send notice to
the Holder of such event and change (the “Price Notice”). The Price Notice shall describe
the event causing the change and the method of calculating same and shall be certified as
being true and accurate by the Company’s President and Chief Financial Officer.

8

 

          Section 7.4 Transmittal of Notices. All notices, requests, consents and other
communications under this Warrant shall be in writing and shall be deemed to have been duly
made on the date of delivery if delivered personally or sent by overnight courier, with
acknowledgement of receipt to the party to which notice is given, or on the fifth day after
mailing if mailed to the party to whom notice is to be given, by registered or certified
mail, return receipt requested, postage prepaid and properly addressed as follows: (i) if
to the registered Holder of the Warrant, to the address of such Holder as shown on the books
of the Company, or (ii) if to the Company, to its principal executive office.

     Section 8. Miscellaneous.

          Section 8.1 Amendments. The Company and Newbridge Securities Corporation may
from time to time supplement or amend this Warrant without the approval of any of the
Holders in order to cure any ambiguity, to correct or supplement any provision contained
herein which may be defective or inconsistent with any other provisions herein, or to make
any other provisions in regard to matters or questions arising hereunder which the Company
and Newbridge Securities Corporation may deem necessary or desirable and which the Company
and Newbridge Securities Corporation deem shall not adversely affect the interest of the
Holders. Any such amendment or supplement shall be in writing executed by the Company and
Newbridge Securities Corporation. All other modifications or amendments shall require the
written consent of the party against whom enforcement of the modification or amendment is
sought.

          Section 8.2 Headings. The headings contained herein are for the sole purpose
of convenience of reference, and shall not in any way limit or affect the meaning or
interpretation of any of the terms or provisions of this Warrant.

          Section 8.3 Entire Agreement. This Warrant (together with the other agreements
and documents being delivered pursuant to or in connection with this Warrant) constitutes
the entire agreement of the parties hereto with respect to the subject matter hereof, and
supersedes all prior agreements and understandings of the parties, oral and written, with
respect to the subject matter hereof.

          Section 8.4 Binding Effect. This Warrant shall inure solely to the benefit of
and shall be binding upon, the Holder and the Company and their respective successors, legal
representatives and assigns, and no other person shall have or be construed to have any
legal or equitable right, remedy or claim under or in respect of or by virtue of this
Warrant or any provisions herein contained.

          Section 8.5 Governing Law; Submission to Jurisdiction. This Warrant shall be
governed by and construed and enforced in accordance with the laws of the State of Colorado,
without giving effect to conflict of laws. The Company hereby agrees that any action,
proceeding or claim against it arising out of, or relating in any way to this Warrant shall
be brought and enforced in the courts of the State of Colorado, and irrevocably submits to
such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any
objection to such exclusive jurisdiction and that such courts represent an inconvenient
forum. Any process or summons to be served upon the Company may be served by transmitting a
copy thereof by registered or certified mail, return receipt requested, postage prepaid,
addressed to Smart Move, Inc., 5990 Greenwood Plaza Boulevard, #2, Suite 390, Greenwood
Village, CO 80111, Attn: Edward Johnson. Such mailing shall be deemed personal service and
shall be legal and binding upon the Company in any action, proceeding or claim. The Company
and the Holder, by

9

 

acceptance hereof, agree that the prevailing party(ies) in any such action shall be
entitled to recover from the other party(ies) all of its reasonable attorneys’ fees and
expenses relating to such action or proceeding and/or incurred in connection with the
preparation therefor.

          Section 8.6 Waiver, Etc. The failure of the Company or the Holder to at any
time enforce any of the provisions of this Warrant shall not be deemed or construed to be a
waiver of any such provision, nor to in any way affect the validity of this Warrant or any
provision hereof or the right of the Company or any Holder to thereafter enforce each and
every provision of this Warrant. No waiver of any breach, non-compliance or non-fulfillment
of any of the provisions of this Warrant shall be effective unless set forth in a written
instrument executed by the party or parties against whom or which enforcement of such waiver
is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be
construed or deemed to be a waiver of any other or subsequent breach, non-compliance or
non-fulfillment.

     IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly authorized
officer as of the ___day of ___, 2006.

	 	 	 	 	 
	 	 	Smart Move, Inc.
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	 	 	Christopher A. Sapyta
	 

	 	 	 	President and Chief Executive Officer

10

 

Form to be used to exercise Warrant:

Smart Move, Inc.

Date:                                        , 200__

        The undersigned hereby elects irrevocably to exercise the within Warrant and to purchase ___
Smart Move, Inc. and hereby makes payment of $                     (at the rate of $                     per Share) in
payment of the Exercise Price pursuant thereto. Please issue the Share as to which this Warrant is
exercised in accordance with the instructions given below.

or

          The undersigned hereby elects irrevocably to exercise the within Warrant and to purchase
                     Smart Move, Inc. by surrender of the unexercised portion of the within Warrant (with a
“Value” of $                     based on a “Market Price” of $                    .) Please issue the Warrant Shares as
to which this Warrant is exercised in accordance with the instructions given below.

	 	 	 
	 

	 	 
	 

	 	Signature

          NOTICE: The signature to this form must correspond with the name as written upon the face of
the within Warrant in every particular without alteration or enlargement or any change whatsoever.

INSTRUCTIONS FOR REGISTRATION OF SECURITIES

	 	 	 
	Name
	 	 
	 

	 	 
	 

	 	(Print in Block Letters)
	 
	 	 
	Address
	 	 
	 

	 	 

11

 

Form to be used to assign Warrant:

ASSIGNMENT

          (To be executed by the registered Holder to effect a transfer of the within Warrant):

          FOR VALUE RECEIVED,                                                          does hereby sell, assign and transfer unto
                                         the right to purchase                                       of Smart Move, Inc.
(“Company”) evidenced by the within Warrant and does hereby authorize the Company to transfer such
right on the books of the Company.

Dated:                                        , 200_

	 	 	 
	 

	 	 
	 

	 	Signature

 

Signature Guaranteed

          NOTICE: The signature to this form must correspond with the name as written upon the face of
the within Warrant in every particular without alteration or enlargement or any change whatsoever,
and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm
having membership on a registered national securities exchange.

12Exhibit 10.39

                              EMPLOYMENT AGREEMENT

         This employment agreement ("Agreement") is made and entered into this
23rd day of August 2006, by and between SPECIALIZED HEALTH PRODUCTS, INC., a
Utah corporation ("Corporation"), and David A. Green ("Employee").

         WHEREAS, Corporation and Employee desire that the term of this
Agreement begin on September 1, 2006 ("Effective Date").

         WHEREAS, Corporation desires to employ Employee as its Chief Financial
Officer and Employee is willing to accept such employment by Corporation, on the
terms and subject to the conditions set forth in this Agreement.

NOW THEREFORE, IT IS AGREED AS FOLLOWS:

         Section 1. Duties. During the term of this Agreement, Employee agrees
to be employed by and to serve Corporation on a full time basis as its Chief
Financial Officer, and Corporation agrees to employ and retain Employee in such
capacities. Employee shall also be appointed to the Corporation's Executive
Committee. Employee shall report to the Corporation's President and Chief
Executive Officer and at all times during the term of this Agreement shall have
powers and duties at least commensurate with his position as Chief Financial
Officer.

         Section 2. Term of Employment.

         2.1 Definitions. For the purposes of this Agreement the following terms
shall have the following meanings:

                  2.1.1 "Termination For Cause" shall mean termination by
Corporation of Employee's employment by Corporation by reason of Employee's
willful dishonesty towards, fraud upon, or deliberate injury or attempted injury
to, Corporation or by reason of Employee's willful material breach of this
Agreement which has resulted in material injury to Corporation.

                  2.1.2 "Termination Other Than For Cause" shall mean
termination by Corporation of Employee's employment by Corporation (other than
in a Termination for Cause) and shall include constructive termination of
Employee's employment by reason of material breach of this Agreement by
Corporation, such constructive termination to be effective upon notice from
Employee to Corporation of such constructive termination.

                  2.1.3 "Voluntary Termination" shall mean termination by
Employee of Employee's employment by Corporation other than (i)Termination Other
Than For Cause, and (ii) termination by reason of Employee's death or disability
as described in Sections 2.5 and 2.6.

         2.2 Term. The employment of Employee by Corporation shall be "at will".

         2.3 Termination For Cause. Termination For Cause may be effected by
Corporation at any time during the term of this Agreement and shall be effected
by written notification to Employee. Upon Termination For Cause, Employee shall
promptly be paid all accrued salary, bonus compensation to the extent earned,
vested deferred compensation (other than pension plan, profit sharing plan and
stock option plan benefits which will be paid in accordance with the applicable
plan), any benefits under any plans of the Corporation in which Employee is a
participant to the full extent of Employee's rights under such plans, accrued
vacation pay and any appropriate business expenses incurred by Employee in
connection with his duties hereunder, all to the date of termination, but
Employee shall not be paid any other compensation or reimbursement of any kind,
including without limitation, severance compensation.

         2.4 Termination Other Than For Cause. Notwithstanding anything else in
this Agreement, Corporation may effect a Termination Other Than For Cause at any
time upon giving written notice to Employee of such termination. Upon any
Termination Other Than For Cause, Employee shall promptly be paid all accrued
salary, bonus compensation to the extent earned, vested deferred compensation
(other than pension plan, profit sharing plan and stock option plan benefits
which will be paid in accordance with the applicable plan), any benefits under
any plans of the Corporation in which Employee is a participant to the full
extent of Employee's rights under such plans (other than pension plan, profit
sharing plan and stock option plan benefits which will be paid in accordance
with the applicable plan), accrued vacation pay and any appropriate business
expenses incurred by Employee in connection with his duties hereunder, all to
the date of termination, with the exception of salary and medical benefits which
shall continue for a period of three (3) months, so long as Employee complies
with the provisions of Sections 5 through 8. In the event of a merger,
acquisition, or substantial sale of Corporation's controlling shares wherein the
Corporation is no longer the controlling entity, if Employee is not offered an
equivalent position, Employee shall be entitled to severance pay and medical
benefits for a period of six (6) months, so long as Employee complies with the
provisions of Sections 5 through 8.

         2.5 Termination by Reason of Disability. If, during the term of this
Agreement, Employee, in the reasonable judgment of the Board of Directors of
Corporation, has failed to perform his duties under this Agreement on account of
illness or physical or mental incapacity, and such illness or incapacity
continues for a period of more than twelve (12) consecutive months, Corporation
shall have the right to terminate Employee's employment hereunder by written
notification to Employee and payment to Employee of all accrued salary, bonus
compensation to the extent earned, vested deferred compensation (other than
pension plan, profit sharing plan and stock option plan benefits which will be
paid in accordance with the applicable plan), any benefits under any plans of
the Corporation in which Employee is a participant to the full extent of
Employee's rights under such plans, accrued vacation pay and any appropriate
business expenses incurred by Employee in connection with his duties hereunder,
all to the date of termination.

         2.6 Death. In the event of Employee's death during the term of this
Agreement, Employee's employment shall be deemed to have terminated as of the
last day of the month during which his death occurs and Corporation shall
promptly pay to his estate or such beneficiaries as Employee may from time to
time designate all accrued salary, bonus compensation to the extent earned,
vested deferred compensation (other than pension plan, profit sharing plan and
stock option plan benefits which will be paid in accordance with the applicable
plan), any benefits under any plans of the Corporation in which Employee is a
participant to the full extent of Employee's rights under such plans, accrued
vacation pay and any appropriate business expenses incurred by Employee in
connection with his duties hereunder, all to the date of termination, but
Employee's estate shall not be paid any other compensation or reimbursement of
any kind, including without limitation, severance compensation.

         2.7 Notice of Termination. Corporation may effect a termination of this
Agreement pursuant to the provisions of this Section upon giving thirty (30)
days' written notice to Employee of such termination.

Section 3. Salary, Benefits and Bonus Compensation.

         3.1 Base Salary. As payment for the services to be rendered by Employee
as provided in Section 1 and subject to the terms and conditions of Section 2,
Corporation agrees to pay to Employee a "Base Salary" for the twelve (12)
calendar months beginning the Effective Date at the rate of $190,000 per annum
payable in no fewer than 12 equal monthly installments of $15,833.33. Employee's
Base Salary shall be reviewed annually by the Compensation Committee of the
Board of Directors ("Compensation Committee"), and the Base Salary for each year
(or portion thereof) shall be determined by the Compensation Committee which
shall authorize an increase in Employee's Base Salary for such year in an amount
which, at a minimum, shall be equal to the cumulative cost-of-living as
determined by the Corporation's board of directors.

         3.2 Bonuses. Beginning in the year 2007, Employee shall be eligible to
participate in the Corporation's executive bonus plan and receive a
discretionary bonus for each year (or portion thereof) during the term of this
Agreement and any extensions thereof, with the actual amount of any such bonus
to be determined in the sole discretion of the Board of Directors based upon its
evaluation of Employee's performance during such year.

         3.3 Additional Benefits. During the term of this Agreement, Employee
shall be entitled to the following fringe benefits:

                  3.3.1 Employee Benefits. Employee shall be eligible to
participate in such of Corporation's benefits and deferred compensation plans as
are now generally available or later made generally available to the officers of
the Corporation.

                  3.3.2 Vacation. Employee shall be entitled to four (4) weeks
of paid vacation during each year during the term of this Agreement and any
extensions thereof, prorated for partial years.

         3.3.3 Life Insurance. For the term of this Agreement and any extensions
thereof, Corporation shall at its expense procure and keep in effect term life
insurance on the life of Employee payable to the Employee's designee in the
aggregate amount of twice Employee's base annual salary.

                  3.3.4 Reimbursement for Expenses. During the term of this
Agreement, Corporation shall reimburse Employee for reasonable and properly
documented out-of-pocket business and/or entertainment expenses incurred by
Employee in connection with his duties under this Agreement.

                  3.3.5 Restricted Stock. Subject to execution of a Restricted
Stock Agreement under the Company's 2004 Stock Incentive Plan, employee shall be
granted 200,000 shares of restricted stock which will vest over three years,
with 33.3% of the restricted stock vesting on the annual anniversary of the date
on which the restricted stock is issued to Employee. Notwithstanding the
foregoing, 50% of the restricted stock will immediately vest in full in the
event of a merger, acquisition, or substantial sale of Corporation's controlling
shares wherein the Corporation is no longer the controlling entity. In such
case, the remaining 50% of the restricted stock will vest according to the
original vesting schedule so long as Employee continues to be employed by the
Corporation or upon termination or constructive termination (whereby Employee is
not offered an equivalent position or is asked to move more than 75 miles for
the equivalent position or Termination Other Than For Cause) within twelve
months of the merger, acquisition, or substantial sale of Corporation's
controlling shares wherein the Corporation is no longer the controlling entity.
Employee shall be eligible for additional grants of restricted stock during the
term of this Agreement, with the actual amount of any such additional grant of
restricted stock to be determined in the sole discretion of the Board of
Directors.

                  3.3.6 Relocation. Corporation will reimburse Employee for
reasonable relocation expenses, which shall include travel and lodging in Salt
Lake City, temporary lodging for Employee's family for up to 4 months, and
household moving expenses. The total relocation expenses for which Employee may
receive reimbursement for shall not exceed $50,000. Employee is required to
relocate to the Salt Lake City area by no later than January 2007.

         Section 4. Ownership of Work Product. Work Product shall include all
copyrights, patents, trade secrets, or other intellectual property rights
associated with any ideas, concepts, techniques, inventions, processes, or works
of authorship developed or created by Employee during the course of performing
work for SHP, whether or not during normal hours of employment, which relate to
the actual or anticipated business of SHP at the time of such development or
creation, or related to actual or anticipated research and development
(collectively, the "Work Product"). Work Product excludes ideas, concepts,
techniques, inventions, processes, or works of authorship developed or created
by Employee (collectively, "New Product Idea") reduced to writing and witnessed
before SHP is in a business related to the New Product Idea and any previous
contracts or licensing arrangements and personal property of Employee at the
time of employment listed on the attached statement, affixed hereto, if any. Any
exceptions must be reviewed and found to be not related to any business that SHP
anticipates or is already engaged and subsequently approved by the Executive
Committee. Work Product shall belong exclusively to SHP. Employee automatically
assigns, at the time of creation of the Work Product, without any requirement of
further consideration, any title, or interest it or they may have in such Work
Product, including any copyrights or other intellectual property rights
pertaining thereto, all such Work Product. Upon request of SHP, Employee shall
take such further actions including execution and delivery of instruments of
conveyance, as may be appropriate to give full and proper effect to such
assignment.

         Section 5. Non-Compete. In recognition and consideration of Employee's
employment, compensation and benefits, the training in and information regarding
SHP's business which SHP will give Employee, Employee's introduction to SHP's
customers, and the carefully guarded methods of doing business which SHP
utilizes and deems crucial to the success of its business, Employee shall not
during the term of this Agreement, and during the period for which Employee
receives severance payments following the termination of Employee's employment
with SHP, regardless of the reason for termination, either directly or
indirectly, engage in the business of developing, marketing, distributing,
licensing, and/or selling products or services having any function similar to,
competitive with, or substitutable for, SHP's products or services which are in
the research and/or development stage and/or for which development has been
completed (collectively and individually, the "Products"), anywhere in the
United States, except with SHP's consent (which may be withheld in SHP's sole
discretion). In addition, Employee shall not engage in any such activity,
directly or indirectly, on Employee's own behalf or in the service of or on
behalf of others. Employee acknowledges and agrees that the current market for
the Products extends throughout the entire United States, and it is therefore
reasonable to prohibit Employee from competing with SHP anywhere in the United
States.

         Section 6. Confidentiality. Employee will hold in a fiduciary capacity
for the benefit of Corporation, its affiliates, subsidiaries, related entities,
and designees, and shall not disclose to any person or entity other than
Corporation or persons or entities designated by Corporation, any secret,
confidential or proprietary information, knowledge, data and/or information,
patents, trade secrets, customer identities, marketing and other business
methods, techniques, processes, practices, procedures, plans and strategies
regarding Corporation, its subsidiaries and affiliated corporations or business
enterprises, and their customers obtained by Employee in the course of
Employee's employment with Corporation, and any other secret, confidential or
proprietary information pertaining to Corporation, its parent, subsidiaries and
affiliated corporations or business enterprises, and their customers, during the
term of this Agreement and five (5) years after Employee's termination of
employment with Corporation, unless Corporation in writing consents to the
contrary. Notwithstanding the foregoing, Employee shall have no confidentiality
obligation with respect to information that: (a) was legally in the public
domain prior to the time of disclosure to the Employee, (b) is now or
subsequently becomes generally available to the public through no fault of
Employee; or (c) is required by law, regulation, rule, act, or order of any
governmental authority or agency to be disclosed by the Employee.

         Section 7. Return of Materials. Immediately upon notice of termination
of employment, Employee shall give to Corporation the originals and all copies
of all documents, correspondence, memoranda, records, notes, manuals, materials,
customer and prospective customer lists and information, including without
limitation computer data, and other things relating to Corporation's business,
including, but not limited to, secret, confidential or proprietary information,
in Employee's possession, custody or control, unless otherwise agreed to by
Corporation.

         Section 8. Non-Solicitation. Employee shall not during the term of this
Agreement, and for a period of twelve (12) months following termination of
employment with Corporation, employ, solicit for employment, or advise or
recommend to any other person that they employ or solicit for employment or
retention as a consultant, any person who is, or was at any time within one (1)
year prior to the Employee's date of termination of employment with Corporation,
an employee of, or exclusive consultant to, Corporation.

         Section 9. Avoidance of Conflict of Interest. While employed by
Corporation and during the period for which Employee receives severance payments
following termination of employment with Corporation, Employee shall not engage
in any other business activity that conflicts with Employee's duties to
Corporation. Under no circumstances may Employee work for any competitor or have
any financial interest in any competitor of Corporation; provided, however, that
this Agreement does not prohibit investment of a reasonable part of Employee's
assets in the stock or securities of any competitor whose stock or securities
are traded on a national exchange.

         Section 10. Withholdings. All compensation and benefits to Employee
hereunder shall be reduced by all federal, state, local and other withholdings
and similar taxes and payments required by applicable law.

         Section 11. Indemnification. In addition to any rights to
indemnification to which Employee is entitled to under the Corporation's
Articles of Incorporation and Bylaws, Corporation shall indemnify Employee at
all times during and after the term of this Agreement to the maximum extent
permitted under Utah Revised Business Corporation Act or any successor provision
thereof and any other applicable state law, and shall pay Employee's expenses in
defending any civil or criminal action, suit, or proceeding in advance of the
final disposition of such action, suit or proceeding, to the maximum extent
permitted under such applicable state laws.

         Section 12. Notices. Any notices permitted or required under this
Agreement shall be deemed given upon the date of personal delivery or
forty-eight (48) hours after deposit in the United States mail, postage fully
prepaid, return receipt requested, addressed to the Corporation at:

         585 West 500 South
         Bountiful, Utah 84010

         addressed to the Employee at:

         ====================

or at any other address as any party may, from time to time, designate by notice
given in compliance with this Section.

         Section 13. Law Governing. This Agreement shall be governed by and
construed in accordance with the laws of the State of Utah.

         Section 14. Titles and Captions. All section titles or captions
contained in this Agreement are for convenience only and shall not be deemed
part of the context nor effect the interpretation of this Agreement.

         Section 15. Entire Agreement. This Agreement contains the entire
understanding between and among the parties and supersedes any prior
understandings and agreements among them respecting the subject matter of this
Agreement.

         Section 16. Agreement Binding. This Agreement shall be binding upon the
heirs, executors, administrators, successors and assigns of the parties hereto.

         Section 17. Attorney Fees. In the event an arbitration, suit or action
is brought by any party under this Agreement to enforce any of its terms, or in
any appeal therefrom, it is agreed that the prevailing party shall be entitled
to reasonable attorneys fees to be fixed by the arbitrator, trial court, and/or
appellate court.

         Section 18. Computation of Time. In computing any period of time
pursuant to this Agreement, the day of the act, event or default from which the
designated period of time begins to run shall be included, unless it is a
Saturday, Sunday, or a legal holiday, in which event the period shall begin to
run on the next day which is not a Saturday, Sunday, or legal holiday, in which
event the period shall run until the end of the next day thereafter which is not
a Saturday, Sunday, or legal holiday.

         Section 19. Pronouns and Plurals. All pronouns and any variations
thereof shall be deemed to refer to the masculine, feminine, neuter, singular,
or plural as the identity of the person or persons may require.

         Section 20. Presumption. This Agreement or any section thereof shall
not be construed against any party due to the fact that said Agreement or any
section thereof was drafted by said party.

         Section 21. Further Action. The parties hereto shall execute and
deliver all documents, provide all information and take or forbear from all such
action as may be necessary or appropriate to achieve the purposes of the
Agreement.

         Section 22. Parties in Interest. Nothing herein shall be construed to
be to the benefit of any third party, nor is it intended that any provision
shall be for the benefit of any third party.

         Section 23. Savings Clause. If any provision of this Agreement, or the
application of such provision to any person or circumstance, shall be held
invalid, the remainder of this Agreement, or the application of such provision
to persons or circumstances other than those as to which it is held invalid,
shall not be affected thereby.

         IN WITNESS WHEREOF, the undersigned have caused this Agreement to be
duly executed.

SPECIALIZED HEALTH PRODUCTS, INC.                   EMPLOYEE

By: /s/ Jeff Soinski                                /s/ David A. Green
    -------------------------------                 ------------------
Its: President                                      David A. Green

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00112-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00112-of-00352.parquet"}]]